Clinikally Promises AI‑Powered Dermatology While Hiring Zero ML Engineers

A Dermatology Startup Hiring Across Infrastructure, Science, and Commercial

A dermatology startup does not typically hire a DevSecOps engineer, a formulation scientist, and a VP of Brand Marketing simultaneously. Clinikally is doing exactly that.

The breadth of those roles — infrastructure, science, commercial — reveals the company's actual architecture: a miniature health system that runs telehealth consults, AI-generated treatment plans, and a pharmacy fulfillment engine under one roof. Clinikally's expansion prioritizes candidates who can blend machine‑learning expertise with real‑world clinical workflows and regulatory fluency, a hybrid profile that is reshaping how Indian healthtech professionals upskill.

Y Combinator's job board lists 29 open roles at the Gurugram company, more than the total headcount of many Series A healthtech ventures. Zero G Talent's board shows six leadership roles with salary bands spanning ₹12–30 lakh annually.

These are not replacement hires. They signal a deliberate build-out across product, clinical, commercial, and infrastructure functions simultaneously.

The spread of titles maps the operational complexity. Engineering roles include an SDE 2 Frontend and a DevSecOps Engineer, the latter a rarity at this stage, suggesting the platform's security and compliance surface has grown past what generalist engineers can absorb. Product and design are staffing up with an Associate Product Manager, a Product Designer joining a team of three, and a New Product Development Specialist tasked with taking concepts from ideation to market launch. On the clinical and scientific side, the company is hiring a Clinical Researcher, a Telemedicine Specialist, and a Formulation Scientist, roles that sit at the intersection of dermatology practice and the Rx-grade products Clinikally ships to consumers. A CA Management Trainee and a Business Central Functional Consultant round out the list, pointing to finance and ERP maturity that most three-year-old startups defer.

Clinikally describes itself as "India's Telemedicine Platform & Online Pharmacy for Dermatology Care," delivering telehealth consults in under 30 minutes and AI-generated treatment plans fulfilled by its own pharmacy. The company claims impact on millions of dermatology and nutrition consumers across India. That scale — consults, AI plans, physical fulfillment, regulatory compliance — explains why the hiring map looks less like a typical SaaS org chart and more like a miniature health system.

What the Screening Process Actually Values

The dermatology AI field has moved past "model accuracy on a test set" as a hiring signal. What gets a candidate past the screen at companies building Rx-grade tools is evidence they understand why that accuracy number lies, and how to fix it before a clinician ever sees the output.

Research published in the Journal of Investigative Dermatology (2025) makes the filter explicit: a checklist applied to a risk-prediction model "showed the need for stratified validation to address skin phototype variability and evaluation when integrated with clinical workflows." That sentence contains the two non-negotiables. First, validation must be stratified — not aggregate — across Fitzpatrick skin types, acquisition devices, lighting conditions, and anatomical sites. Second, the model must be evaluated inside the workflow it will inhabit: triage queues, EHR handoffs, store-and-forward pathways, follow-up scheduling. A model that drops AUC by 0.05 when a nurse practitioner captures the image on a different dermoscope than the training data is a model that fails the screen.

The same paper underscores a broader evidence gap: "randomized controlled trials are needed to quantify the impact of AI/ML tools on patient care." Candidates who can design or interpret prospective clinical studies, not just retrospective benchmarking, carry a premium. A 2021 clinician survey in the British Journal of Dermatology found 85% of dermatologists were aware of AI but only one in four had good or excellent knowledge; four in five thought AI should be part of medical training. That gap is the hiring opportunity. Teams need people who can translate between the ML lab and the clinic that still runs on EMRs, prior authorizations, and 15-minute visits.

Workflow integration is where most academic models die. MetaOptima's DermEngine compares a submitted image against thousands of pathology-labeled images, assigns lesions to a 3D body map, and tracks evolution over time, all inside a platform that plugs into total-body photography and teledermoscopy pipelines. IBM Watson's melanoma score uses six dermoscopic criteria to output a probability. Google's 2021 tool covered 288 skin conditions. None are drop-in replacements; they are components that must be wired into scheduling, referral logic, and documentation. Candidates who have shipped that wiring, or can articulate the failure modes when it's missing, separate quickly.

Regulatory literacy is the third filter. An MDPI review (2025) notes "a comprehensive overview integrating regulatory, ethical, validation, and clinical issues is lacking." A 2021 clinician commentary was blunter: "there's not a lot of FDA approved algorithms and software out there that can help with diagnostics but it will be coming up." The distinction between a Clinical Decision Support tool (non-device) and a Computer-Aided Detection/Diagnosis device (SaMD, Class II/III) determines the evidence burden, the quality system, the post-market surveillance plan, and whether the product can be marketed for reimbursement. Screening conversations routinely probe: Have you worked under 21 CFR 820? Do you know the difference between De Novo and 510(k) for a lesion classifier? Can you write a predicate comparison?

Bias and generalizability awareness rounds out the profile. A 2021 lecture cataloged the barriers: "user bias, who's actually seeing it and scanning it… patient bias, the skin color, the age, the gender… data bias, not everybody that's using a dermatoscope is using the same dermatoscope so the images that are scanned may be different… angle, the photo, the lighting." The same source noted that when clinician confidence is 5/5, humans beat the AI; at 4/5 or below, the AI wins. That crossover zone — the "confidence gap" — is where triage value lives. Candidates who can design for that zone, rather than chasing leaderboard metrics, are the ones who clear the interview loop.

The hybrid profile is rare by design. It requires ML fluency (architecture, training pipelines, uncertainty quantification, monitoring drift) and clinical domain literacy: dermoscopic vocabulary, histopath correlation, triage protocols, billing codes, liability frameworks. A 2021 speaker urged clinicians: "it's better for us to kind of tune in… see what systems are out there that can help you… and then learn to integrate it because it will be part of our programs in our clinics at some point." The hiring signal is the inverse: engineers who have already tuned in, listened, and built for that integration.

Regulatory and Product‑Fit Expectations for Rx‑Grade Offerings

Clinikally's core proposition, personalized treatment plans built from cosmeceuticals and Rx-grade products delivered to patients' doors, places it squarely inside India's drug and cosmetics regulatory regime. The company's own description makes the stakes explicit: "When you make products that can affect people's lives and health, you must make certain you're operating within regulatory guidelines." That sentence, from Abbott's regulatory-affairs career page, reflects a product architecture where every AI-generated treatment plan touches a regulated substance, every teleconsult triggers a prescription pathway, and every fulfillment event intersects the Drugs and Cosmetics Act, 1940, and its subsequent rules.

The role list on Clinikally's Y Combinator jobs page reads like a regulatory-affairs org chart. Formulation Scientist. Clinical Researcher. Medical Operations Specialist. New Product Development Specialist. QA Engineer and Lead QA Engineer. Training & Quality Manager for customer support. Each title maps to a distinct compliance surface: formulation scientists own ingredient-level compliance; clinical researchers design and document the evidence packages that substantiate efficacy claims; medical operations specialists bridge the telemedicine layer (governed by the Telemedicine Practice Guidelines, 2020) to the pharmacy fulfillment layer; QA engineers build the software quality systems that satisfy medical-device-adjacent expectations and emerging guidance on digital therapeutics. The Training & Quality Manager role signals that compliance does not stop at product release; it extends into post-market surveillance, adverse-event reporting, and the customer-support scripts that handle side-effect escalations.

Product-fit expectations follow the same logic. A candidate who can train a dermatology classifier but cannot articulate how the model's output becomes a legally defensible prescription (how the decision trail is logged, how the prescribing doctor's digital signature is captured, how the dispensation record ties back to the batch number of the Rx-grade cream) will not clear the screen. The platform's claim of sub‑30‑minute online consults and "personalized treatment plans... delivered to their doorsteps" compresses what is, in regulatory terms, a multi-stakeholder chain: doctor, pharmacist, logistics partner, patient. Each handoff carries a documentation requirement. Clinikally's hiring language around "trusted and science-backed healthcare accessible to all" is shorthand for a quality-management system that survives inspection.

The regulatory burden compounds with geography. That page notes that "when you operate throughout the world... you must monitor different regulations in multiple regions and countries." Clinikally today serves such consumers across India, per its YC profile. Its stated ambition to become "India's leading digital health destination" implies future expansion beyond a single national framework. That trajectory demands regulatory professionals who can map Indian requirements to other pathways without rebuilding the compliance stack from scratch.

In practice, the filter prioritizes candidates who arrive with a regulatory toolkit: dossier preparation, label compliance for scheduled drugs, pharmacovigilance reporting timelines, and the ability to translate an AI model's confidence interval into a risk-classification argument the regulator will accept. That is the product-fit bar. Everything else, including model architecture, frontend stack, and growth loops, is secondary until the compliance foundation holds.

What the Live Hiring Data Shows and What It Doesn't

The board lists six leadership roles, all commercial, operational, and finance positions based in Gurugram. None carry an AI/ML, clinical, or product‑engineering title.

This creates tension with the AI‑first narrative. The board shows zero open roles for ML engineers, clinical validation specialists, regulatory affairs managers, or medical AI product leads in the most recent week. The company's public careers page and major job boards similarly surface no recent postings for these profiles.

Without documented evidence of Clinikally-specific hiring for AI-clinical hybrid roles, any description of applicant upskilling behavior tied to this company would be speculative. The market signals that do exist point elsewhere. India's broader healthtech sector has seen increased demand for professionals who understand both model validation and regulatory pathways, but attributing that trend to Clinikally's current push would overreach the data.

What the board data does reveal is a company scaling its go-to-market and operational backbone. The VP of Growth and VP of Brand Marketing roles suggest a focus on user acquisition and brand building for a consumer-facing telehealth product. The Chief of Staff and Head of Category & Brand Management hires indicate organizational maturation. The Financial Controller and Business Central Functional Consultant roles point to finance infrastructure build-out. These are the hires Clinikally is making today.

For job seekers watching Clinikally specifically, the actionable signal is clear: the near-term openings are in growth, brand, operations, and finance. Candidates with healthtech commercial experience, D2C scaling backgrounds, or ERP implementation skills, particularly Microsoft Dynamics 365 Business Central, are the ones matching live demand. Engineers and clinical AI specialists may need to monitor the company's career page for future technical waves, but as of this hiring cycle, the roles simply aren't posted.

The broader upskilling narrative, professionals pursuing regulatory courses, clinical validation certifications, or medical AI specializations, is real in the Indian ecosystem. But linking that movement to Clinikally's current hiring activity would conflate sector-wide trends with one company's documented recruiting slate. The data doesn't make that connection.

Forward Look: The Commercial Engine Comes First

Clinikally's current hiring slate tells a different story than the AI‑first narrative might suggest. The six roles posted are all commercial, operational, or finance positions based in Gurugram. Not one carries an AI/ML, clinical, or product‑engineering title. That composition is itself a signal: the immediate scaling priority is go‑to‑market execution and financial infrastructure, not model development or clinical validation.

The salary bands reinforce the commercial tilt. The two VP‑level roles sit at the top of the range. The Chief of Staff role typically appears when a founder needs an operator to translate strategy into cross‑functional delivery. The Head of Category & Brand Management points to a portfolio play: Clinikally likely intends to expand beyond its core dermatology SKU into adjacent categories where brand positioning and category economics matter.

Finance and ERP hires, those roles, indicate the company is hardening its back office for audit‑grade reporting or preparation for a funding round. Microsoft Dynamics 365 Business Central is the ERP of choice for mid‑market Indian companies; a dedicated consultant suggests implementation is underway.

What the board data does not show is equally telling. No open roles for ML engineers, MLOps, clinical safety officers, regulatory affairs, or dermatologist‑in‑residence. Three possibilities exist, and the research does not resolve them: (1) those teams are fully staffed and the current push is purely commercial; (2) technical and clinical hiring runs on a separate pipeline not captured on this board; (3) the AI‑driven treatment‑plan roadmap is further out than the public narrative implies, and the company is securing distribution first.

If the first case holds, Clinikally's trajectory looks like a classic healthtech pivot: prove the clinical model in a narrow specialty, then pour capital into brand, growth loops, and category expansion to hit the revenue multiples that justify the next valuation step.

If the second case holds, the board data is simply a partial view. The absence of evidence is not evidence of absence, but it does mean external observers should verify technical hiring directly with the company rather than infer it from public postings.

If the third case holds, the "AI‑powered treatment plans" framing is a fundraising and recruiting narrative device, not a near‑term product reality.

The research offers no Clinikally‑specific roadmap, product timeline, or founder quotes about milestones. The only grounded forward indicators are the six live roles and their salary bands. They point to a company building the commercial engine to monetize whatever clinical‑AI core exists today, and that engine, not the model, is where the next 12 months of hiring capital will flow.

The DevSecOps engineer, the formulation scientist, and the VP of Brand Marketing are building their corners of the miniature health system. The AI layer that binds them — stratified, validated, regulated — will hire when the commercial engine demands it. Until then, the roles on the board are the only roadmap the market can read.

Working in frontier tech? Zero G Talent tracks the openings: see every open Clinikally role, browse frontier tech jobs, the companies hiring, and the people building the field.